YOU ARE WATCHING
NOW PLAYING: 5 of 6
CHOP is the principal investigator for the majority of all pediatric trials in the world related to inflammatory bowel disease. New therapies, new diagnostic tools and experimental new drugs are making a difference for children with IBD.
Life Uncommon is a video series about children and adolescents suffering from IBD and the professionals who care for them at the Center for Pediatric Inflammatory Bowel Disease at The Children's Hospital of Philadelphia.
Narrator: The race is on to bring new therapies from bench to bedside. At the heart of everything is research.
Steven M. Altschuler, MD: I would say over the last 3 to 5 years, there has been an explosion of new therapies and diagnostic tools available for the care of patients with Inflammatory Bowel Disease.
Robert N. Baldassano, MD: At this time here at Children's, we are the principal investigator for the majority of all pediatric trials that are going on in Inflammatory Bowel Disease in the world.
Aimee E. Christian, PhD: We have one industry sponsor trial looking at an experimental new drug.
Child: The bottom of my feet were hurting on Saturday.
Robert N. Baldassano, MD: Okay. Okay. We will need to make that better.
Aimee E. Christian, PhD: We have one patient enrolled in that study right now, and she's actually doing amazing. She had been on high doses of steroids for 8 years, and now she's been weaned to less than 10 milligrams a day.
Child: It's a PIC line, which is a Central Line that is inserted through here, goes up my arm, close to my heart, in a major artery to my heart.
Contact the Center for Pediatric Inflammatory Bowel Disease.